Navigation Links
Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
Date:4/15/2008

ng and dosing patients and the two other trials are expected to begin shortly. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

No. 4079: Monica L. Friedrich, Claudia I. Guevara, Daniel M. Falcon, Longen Zhou, Connie Chang and Bruce Freimark, Antibody targeting of phosphatidylserine produces a cytokine microenvironment that enhances innate anti-tumor immune responses, Peregrine Pharmaceuticals, Inc., April 15, 2008, 8:00 AM - 11:00 AM PDT

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that results from future preclinical studies and clinical trials will not correlate with the results of these preclinical studies. It is important to note that the company's ac
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
2. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
3. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
4. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
7. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
8. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
9. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
10. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
11. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... -- Indianapolis interventional medical device maker NICO Corporation ... visualization leader Synaptive Medical announced today ... that they have joined forces to integrate their ... the first of its kind and will make ... BrainPath® interventional access technology and Synaptive,s BrightMatter™ real-time ...
(Date:10/20/2014)... 20, 2014 Valeritas, Inc., a leader in ... with Type 2 diabetes, announced today that it has ... The award was presented October 16 th at ... Ohio . The Cardinal Health ... variety of metrics specifically targeted at the importance of ...
(Date:10/20/2014)... PRINCETON, N.J. , Oct. 20, 2014 /PRNewswire/ ... Taiho Pharmaceutical Co., Ltd. ( Japan ... Administration (FDA) granted Fast Track designation for TAS-102 ... combination anticancer drug under investigation for the treatment ... the Company has initiated a rolling NDA submission ...
Breaking Medicine Technology:Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 2Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 3Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer 4
... PHILADELPHIA, Sept. 15 Asthma researchers,have found that a ... asthma,in European children plays a similar role in white ... most common chronic illness among children in the developed ... of genes are thought to,interact with each other and ...
... Clinical Psychopharmacology ... Meeting, WELLESLEY ... the assets of Spherics, Inc. ("Spherics") for,the benefit of creditors, announced today ... bid auction on October 10,2008., Topamax(R) produces adverse effects on cognitive ...
Cached Medicine Technology:More Findings on Gene Involved in Childhood Asthma 2More Findings on Gene Involved in Childhood Asthma 3Spherics, Inc. Announces Reduced Cognitive Impairment of Novel Extended Release Topiramate (SRx-502) as Compared to Topamax(R) 2
(Date:10/20/2014)... Oregon (PRWEB) October 20, 2014 Succeed is ... of local companies who participated in the Every Body ... is a public awareness project that encourages workers to be ... Summer Step 10,000 Program, which concluded at the end of ... variety of cities and metro areas. Participating companies gave ...
(Date:10/20/2014)... DALLAS (PRWEB) October 20, 2014 It’s hard ... for many orphans and vulnerable children around the world, it’s ... by some people, many children are forced to walk barefoot ... for their families or play with their friends. , ... partnering with Air1 Radio in October to encourage ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently ... are the best Dedicated Server Hosting suppliers. Their ... to buy high quality hosting and save money ... of Top10BestSEOHosting.com says, “We believe that iPage and ... A lot of the global clients enjoy using ...
(Date:10/19/2014)... 20, 2014 Recently, Top10BestSEOHosting.com has ... that JustHost, GoDaddy and HostMonster are the best ... (Virtual Private Server) is the method of partitioning ... of which has the appearance and capabilities of ... why the site pays close attention to VPS ...
(Date:10/19/2014)... 2014 (HealthDay News) -- New stem cell-based research could ... new treatments, a new study suggests. Scientists used ... tissue in a lab dish. They then transplanted the ... intestinal disorders, according to the researchers. "This provides ... conditions that can cause intestinal failure, from genetic disorders ...
Breaking Medicine News(10 mins):Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2
... 21 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide announced today that it will ... from October,29 to November 1., Mindray will ... core product,segments: patient monitoring & life support products, ...
... -- Total revenues of $1.8 billion, up 3.4% -- ... -- Cash flow from operations improved to $329 million ... per diluted share -- Agreement in principle reached regarding ... N.J., Oct. 21 , 2008-- Quest,Diagnostics Incorporated (NYSE: DGX ...
... test has been developed to measure the effectiveness of Aspirin Therapy, based ... the benefits of taking aspirin on a daily basis. The Aspirin ... the patient, resulting in further prevention of heart attacks. , ... Los ...
... iPhone and iPod Touch, is released today worldwide. Simple spoken instructions ... Resuscitation or how to act when someone is choking. , ... ... an application for iPhone and iPod Touch, is released today worldwide. ...
... Sexual Health Foundation (TWSHF) released an issue of the Women,s Sexual ... the Foundation frequently addresses with healthcare professionals, cancer patients and survivors. ... discussed prior to or after their cancer treatment relating to intimacy ... ...
... Mexico at fraction of the US cost. Andy got several fillings ... sitting. Overseas Dentistry, including dental implants abroad cost a ... ... (PRWEB) October 21, 2008 -- Andy Gobienko was eating a burger the ...
Cached Medicine News:Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 2Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 3Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 4Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 5Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 6Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 7Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 8Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 9Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 10Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 11Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 12Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 13Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 14Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 15Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 16Health News:Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008 17Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 2Health News:Breakthrough Testing for Patients on Aspirin Therapy for Preventing Heart Attacks 3Health News:Save Lives with Your Mobile Phone - Doctor Releases First Aid Application for iPhone 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 2Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 3Health News:Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed 4Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
The ACP 215 is the automated closed system cell processor with integrated process control....
... throughout the world are facing difficult times ... of the blood supply in the face ... donor base. Clearly, these centers must find ... manage their existing donor pools, and to ...
The Plasma Extractor is used to express blood components from collection containers. The spring-loaded front panel exerts pressure on the collection container causing the fluid to transfer until cont...
The Eppendorf Maxipettor is a continuously adjustable pipette for precise pipetting of volumes up to 10 ml (in 10 l increments). Even liquids with a high vapor pressure or viscosity can be pipetted w...
Medicine Products: